nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP1A2—Clobetasol propionate—psoriasis	0.0712	0.117	CbGbCtD
Sertraline—CYP2B6—Cholecalciferol—psoriasis	0.0423	0.0692	CbGbCtD
Sertraline—CYP1A2—Methoxsalen—psoriasis	0.0374	0.0613	CbGbCtD
Sertraline—CYP2D6—Hydroxyurea—psoriasis	0.0337	0.0552	CbGbCtD
Sertraline—CYP2C19—Cholecalciferol—psoriasis	0.0269	0.044	CbGbCtD
Sertraline—CYP3A4—Calcitriol—psoriasis	0.0252	0.0413	CbGbCtD
Sertraline—CYP2C9—Cholecalciferol—psoriasis	0.0223	0.0366	CbGbCtD
Sertraline—CYP2D6—Cholecalciferol—psoriasis	0.0204	0.0334	CbGbCtD
Sertraline—CYP3A4—Methoxsalen—psoriasis	0.0196	0.0321	CbGbCtD
Sertraline—ABCB1—Mycophenolate mofetil—psoriasis	0.0188	0.0308	CbGbCtD
Sertraline—CYP2C19—Prednisone—psoriasis	0.0186	0.0305	CbGbCtD
Sertraline—CYP2B6—Dexamethasone—psoriasis	0.0183	0.03	CbGbCtD
Sertraline—CYP2C19—Cyclosporine—psoriasis	0.0177	0.0289	CbGbCtD
Sertraline—ABCB1—Betamethasone—psoriasis	0.0161	0.0264	CbGbCtD
Sertraline—ABCB1—Prednisolone—psoriasis	0.0159	0.026	CbGbCtD
Sertraline—ABCB1—Hydrocortisone—psoriasis	0.0151	0.0247	CbGbCtD
Sertraline—ABCB1—Prednisone—psoriasis	0.015	0.0246	CbGbCtD
Sertraline—CYP2C9—Cyclosporine—psoriasis	0.0147	0.024	CbGbCtD
Sertraline—ABCB1—Cyclosporine—psoriasis	0.0142	0.0233	CbGbCtD
Sertraline—CYP2D6—Cyclosporine—psoriasis	0.0134	0.022	CbGbCtD
Sertraline—CYP3A4—Cholecalciferol—psoriasis	0.013	0.0213	CbGbCtD
Sertraline—CYP2C19—Dexamethasone—psoriasis	0.0116	0.019	CbGbCtD
Sertraline—CYP3A4—Mycophenolate mofetil—psoriasis	0.0113	0.0184	CbGbCtD
Sertraline—CYP3A4—Triamcinolone—psoriasis	0.0113	0.0184	CbGbCtD
Sertraline—CYP2C9—Dexamethasone—psoriasis	0.00967	0.0158	CbGbCtD
Sertraline—CYP3A4—Betamethasone—psoriasis	0.00966	0.0158	CbGbCtD
Sertraline—CYP3A4—Prednisolone—psoriasis	0.00953	0.0156	CbGbCtD
Sertraline—ABCB1—Dexamethasone—psoriasis	0.00938	0.0154	CbGbCtD
Sertraline—CYP3A4—Hydrocortisone—psoriasis	0.00904	0.0148	CbGbCtD
Sertraline—CYP3A4—Prednisone—psoriasis	0.009	0.0147	CbGbCtD
Sertraline—CYP2D6—Dexamethasone—psoriasis	0.00884	0.0145	CbGbCtD
Sertraline—CYP3A4—Cyclosporine—psoriasis	0.00853	0.014	CbGbCtD
Sertraline—ABCB1—Methotrexate—psoriasis	0.00754	0.0123	CbGbCtD
Sertraline—CYP3A4—Dexamethasone—psoriasis	0.00562	0.0092	CbGbCtD
Sertraline—CYP2B6—CYP2E1 reactions—CYP2S1—psoriasis	0.0017	0.0542	CbGpPWpGaD
Sertraline—CYP2C19—CYP2E1 reactions—CYP2S1—psoriasis	0.00128	0.0409	CbGpPWpGaD
Sertraline—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.00118	0.0376	CbGpPWpGaD
Sertraline—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.00117	0.0373	CbGpPWpGaD
Sertraline—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.0011	0.0351	CbGpPWpGaD
Sertraline—SIGMAR1—Levonorgestrel—Hydrocortisone—psoriasis	0.00106	1	CbGdCrCtD
Sertraline—CYP2B6—Xenobiotics—CYP2S1—psoriasis	0.00105	0.0336	CbGpPWpGaD
Sertraline—MAOB—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000901	0.0287	CbGpPWpGaD
Sertraline—CYP2C19—Xenobiotics—CYP2S1—psoriasis	0.000795	0.0254	CbGpPWpGaD
Sertraline—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000731	0.0233	CbGpPWpGaD
Sertraline—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000724	0.0231	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL22—psoriasis	0.000622	0.0199	CbGpPWpGaD
Sertraline—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000619	0.0198	CbGpPWpGaD
Sertraline—MAOA—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000565	0.018	CbGpPWpGaD
Sertraline—MAOB—Biological oxidations—CYP2S1—psoriasis	0.000478	0.0153	CbGpPWpGaD
Sertraline—CYP3A4—Xenobiotics—CYP2S1—psoriasis	0.000478	0.0153	CbGpPWpGaD
Sertraline—CYP2B6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000437	0.0139	CbGpPWpGaD
Sertraline—CYP2B6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000431	0.0138	CbGpPWpGaD
Sertraline—MAOB—Tryptophan metabolism—CAT—psoriasis	0.000413	0.0132	CbGpPWpGaD
Sertraline—MAOA—Oxidative Stress—CAT—psoriasis	0.000365	0.0116	CbGpPWpGaD
Sertraline—CYP2B6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000354	0.0113	CbGpPWpGaD
Sertraline—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.00033	0.0105	CbGpPWpGaD
Sertraline—CYP2C19—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000326	0.0104	CbGpPWpGaD
Sertraline—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000303	0.00969	CbGpPWpGaD
Sertraline—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000301	0.0096	CbGpPWpGaD
Sertraline—MAOA—Biological oxidations—CYP2S1—psoriasis	0.0003	0.00958	CbGpPWpGaD
Sertraline—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000299	0.00956	CbGpPWpGaD
Sertraline—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000297	0.00948	CbGpPWpGaD
Sertraline—MAOA—Melatonin metabolism and effects—APOE—psoriasis	0.000291	0.00929	CbGpPWpGaD
Sertraline—CYP2C19—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000267	0.00854	CbGpPWpGaD
Sertraline—ABCB1—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000258	0.00822	CbGpPWpGaD
Sertraline—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000257	0.00821	CbGpPWpGaD
Sertraline—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000255	0.00814	CbGpPWpGaD
Sertraline—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000254	0.0081	CbGpPWpGaD
Sertraline—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000246	0.00785	CbGpPWpGaD
Sertraline—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000244	0.00779	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000227	0.00726	CbGpPWpGaD
Sertraline—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000226	0.00721	CbGpPWpGaD
Sertraline—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000208	0.00665	CbGpPWpGaD
Sertraline—SLC6A4—NRF2 pathway—TGFA—psoriasis	0.000204	0.00651	CbGpPWpGaD
Sertraline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000201	0.0064	CbGpPWpGaD
Sertraline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000198	0.00633	CbGpPWpGaD
Sertraline—CYP3A4—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000196	0.00625	CbGpPWpGaD
Sertraline—CYP2B6—Biological oxidations—CYP2S1—psoriasis	0.000188	0.006	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000186	0.00595	CbGpPWpGaD
Sertraline—CYP2B6—Metapathway biotransformation—CYP2S1—psoriasis	0.000185	0.00592	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL13—psoriasis	0.00018	0.00573	CbGpPWpGaD
Sertraline—SLC6A2—NRF2 pathway—TGFA—psoriasis	0.000175	0.0056	CbGpPWpGaD
Sertraline—MAOA—Melatonin metabolism and effects—NFKB1—psoriasis	0.000173	0.00553	CbGpPWpGaD
Sertraline—MAOA—Oxidative Stress—NFKB1—psoriasis	0.000168	0.00538	CbGpPWpGaD
Sertraline—CYP3A4—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000161	0.00513	CbGpPWpGaD
Sertraline—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—psoriasis	0.000159	0.00507	CbGpPWpGaD
Sertraline—SLC6A3—NRF2 pathway—TGFA—psoriasis	0.000155	0.00496	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—CP—psoriasis	0.000153	0.00488	CbGpPWpGaD
Sertraline—SLC6A4—Monoamine Transport—TNF—psoriasis	0.000152	0.00485	CbGpPWpGaD
Sertraline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000148	0.00472	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL13—psoriasis	0.000147	0.0047	CbGpPWpGaD
Sertraline—CYP2C19—Biological oxidations—CYP2S1—psoriasis	0.000142	0.00454	CbGpPWpGaD
Sertraline—SLC6A3—Dopaminergic Neurogenesis—STAT3—psoriasis	0.000141	0.00449	CbGpPWpGaD
Sertraline—CYP2C19—Metapathway biotransformation—CYP2S1—psoriasis	0.00014	0.00447	CbGpPWpGaD
Sertraline—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.00014	0.00446	CbGpPWpGaD
Sertraline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000138	0.00441	CbGpPWpGaD
Sertraline—CYP2C19—Melatonin metabolism and effects—APOE—psoriasis	0.000138	0.0044	CbGpPWpGaD
Sertraline—CYP2D6—Biological oxidations—CYP2S1—psoriasis	0.000131	0.00417	CbGpPWpGaD
Sertraline—SLC6A2—Monoamine Transport—TNF—psoriasis	0.000131	0.00417	CbGpPWpGaD
Sertraline—CYP2C9—Biological oxidations—CYP2S1—psoriasis	0.00013	0.00414	CbGpPWpGaD
Sertraline—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	0.000129	0.00411	CbGpPWpGaD
Sertraline—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	0.000128	0.00408	CbGpPWpGaD
Sertraline—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	0.000127	0.00404	CbGpPWpGaD
Sertraline—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	0.000126	0.00402	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	0.000123	0.00394	CbGpPWpGaD
Sertraline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	0.000118	0.00377	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-C—psoriasis	0.000118	0.00376	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL13—psoriasis	0.000117	0.00374	CbGpPWpGaD
Sertraline—SLC6A2—SLC-mediated transmembrane transport—CP—psoriasis	0.000116	0.0037	CbGpPWpGaD
Sertraline—SLC6A3—Monoamine Transport—TNF—psoriasis	0.000116	0.00369	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL10—psoriasis	0.000112	0.00359	CbGpPWpGaD
Sertraline—CYP1A2—Biological oxidations—CYP2S1—psoriasis	0.000111	0.00353	CbGpPWpGaD
Sertraline—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	0.000109	0.00349	CbGpPWpGaD
Sertraline—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	0.000109	0.00348	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL17A—psoriasis	0.000108	0.00344	CbGpPWpGaD
Sertraline—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	0.000107	0.00343	CbGpPWpGaD
Sertraline—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000103	0.00329	CbGpPWpGaD
Sertraline—SLC6A3—SLC-mediated transmembrane transport—CP—psoriasis	0.000103	0.00328	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL12B—psoriasis	0.0001	0.0032	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-E—psoriasis	9.78e-05	0.00312	CbGpPWpGaD
Sertraline—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	9.63e-05	0.00308	CbGpPWpGaD
Sertraline—MAOB—Metabolism—NDUFA5—psoriasis	9.62e-05	0.00307	CbGpPWpGaD
Sertraline—CYP1A2—Tryptophan metabolism—CAT—psoriasis	9.55e-05	0.00305	CbGpPWpGaD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL10—psoriasis	9.21e-05	0.00294	CbGpPWpGaD
Sertraline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	9.11e-05	0.00291	CbGpPWpGaD
Sertraline—CYP3A4—Biological oxidations—CYP2S1—psoriasis	8.54e-05	0.00273	CbGpPWpGaD
Sertraline—CYP3A4—Metapathway biotransformation—CYP2S1—psoriasis	8.43e-05	0.00269	CbGpPWpGaD
Sertraline—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	8.23e-05	0.00263	CbGpPWpGaD
Sertraline—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	8.19e-05	0.00262	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CYP2S1—psoriasis	8.18e-05	0.00261	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PTTG1—psoriasis	8.1e-05	0.00259	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—LEP—psoriasis	7.55e-05	0.00241	CbGpPWpGaD
Sertraline—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	7.53e-05	0.00241	CbGpPWpGaD
Sertraline—CYP3A4—Tryptophan metabolism—CAT—psoriasis	7.37e-05	0.00235	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL10—psoriasis	7.33e-05	0.00234	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—IL4—psoriasis	7.13e-05	0.00228	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—NOS2—psoriasis	7.03e-05	0.00224	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-B—psoriasis	6.97e-05	0.00223	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—LEP—psoriasis	6.96e-05	0.00222	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—PPARG—psoriasis	6.57e-05	0.0021	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—NOS2—psoriasis	6.49e-05	0.00207	CbGpPWpGaD
Sertraline—ABCB1—Allograft Rejection—HLA-A—psoriasis	6.46e-05	0.00206	CbGpPWpGaD
Sertraline—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	6.38e-05	0.00204	CbGpPWpGaD
Sertraline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	6.35e-05	0.00203	CbGpPWpGaD
Sertraline—Discomfort—Betamethasone—psoriasis	6.32e-05	0.000177	CcSEcCtD
Sertraline—Discomfort—Dexamethasone—psoriasis	6.32e-05	0.000177	CcSEcCtD
Sertraline—Dyspepsia—Hydrocortisone—psoriasis	6.32e-05	0.000177	CcSEcCtD
Sertraline—Haemoglobin—Methotrexate—psoriasis	6.32e-05	0.000177	CcSEcCtD
Sertraline—Rash—Mycophenolic acid—psoriasis	6.3e-05	0.000176	CcSEcCtD
Sertraline—Dermatitis—Mycophenolic acid—psoriasis	6.29e-05	0.000176	CcSEcCtD
Sertraline—Pain—Prednisolone—psoriasis	6.29e-05	0.000176	CcSEcCtD
Sertraline—Haemorrhage—Methotrexate—psoriasis	6.28e-05	0.000176	CcSEcCtD
Sertraline—Hepatitis—Methotrexate—psoriasis	6.28e-05	0.000176	CcSEcCtD
Sertraline—Urticaria—Mycophenolate mofetil—psoriasis	6.26e-05	0.000175	CcSEcCtD
Sertraline—Headache—Mycophenolic acid—psoriasis	6.26e-05	0.000175	CcSEcCtD
Sertraline—Decreased appetite—Hydrocortisone—psoriasis	6.24e-05	0.000175	CcSEcCtD
Sertraline—Pharyngitis—Methotrexate—psoriasis	6.24e-05	0.000175	CcSEcCtD
Sertraline—Abdominal pain—Mycophenolate mofetil—psoriasis	6.23e-05	0.000175	CcSEcCtD
Sertraline—Body temperature increased—Mycophenolate mofetil—psoriasis	6.23e-05	0.000175	CcSEcCtD
Sertraline—Urinary tract disorder—Methotrexate—psoriasis	6.21e-05	0.000174	CcSEcCtD
Sertraline—Gastrointestinal disorder—Hydrocortisone—psoriasis	6.2e-05	0.000174	CcSEcCtD
Sertraline—Fatigue—Hydrocortisone—psoriasis	6.19e-05	0.000174	CcSEcCtD
Sertraline—Urethral disorder—Methotrexate—psoriasis	6.16e-05	0.000173	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Triamcinolone—psoriasis	6.16e-05	0.000173	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—CXCL8—psoriasis	6.14e-05	0.00196	CbGpPWpGaD
Sertraline—Pain—Hydrocortisone—psoriasis	6.14e-05	0.000172	CcSEcCtD
Sertraline—Anaphylactic shock—Betamethasone—psoriasis	6.13e-05	0.000172	CcSEcCtD
Sertraline—Oedema—Dexamethasone—psoriasis	6.13e-05	0.000172	CcSEcCtD
Sertraline—Oedema—Betamethasone—psoriasis	6.13e-05	0.000172	CcSEcCtD
Sertraline—Anaphylactic shock—Dexamethasone—psoriasis	6.13e-05	0.000172	CcSEcCtD
Sertraline—Insomnia—Triamcinolone—psoriasis	6.11e-05	0.000171	CcSEcCtD
Sertraline—Ill-defined disorder—Prednisone—psoriasis	6.07e-05	0.00017	CcSEcCtD
Sertraline—Paraesthesia—Triamcinolone—psoriasis	6.07e-05	0.00017	CcSEcCtD
Sertraline—Feeling abnormal—Prednisolone—psoriasis	6.06e-05	0.00017	CcSEcCtD
Sertraline—Visual impairment—Methotrexate—psoriasis	6.06e-05	0.00017	CcSEcCtD
Sertraline—Anaemia—Prednisone—psoriasis	6.05e-05	0.00017	CcSEcCtD
Sertraline—MAOA—Metabolism—NDUFA5—psoriasis	6.04e-05	0.00193	CbGpPWpGaD
Sertraline—Shock—Dexamethasone—psoriasis	6.04e-05	0.000169	CcSEcCtD
Sertraline—Shock—Betamethasone—psoriasis	6.04e-05	0.000169	CcSEcCtD
Sertraline—Dyspnoea—Triamcinolone—psoriasis	6.03e-05	0.000169	CcSEcCtD
Sertraline—Nervous system disorder—Betamethasone—psoriasis	6.02e-05	0.000169	CcSEcCtD
Sertraline—Nervous system disorder—Dexamethasone—psoriasis	6.02e-05	0.000169	CcSEcCtD
Sertraline—Agitation—Prednisone—psoriasis	6.02e-05	0.000169	CcSEcCtD
Sertraline—Thrombocytopenia—Betamethasone—psoriasis	6.01e-05	0.000168	CcSEcCtD
Sertraline—Thrombocytopenia—Dexamethasone—psoriasis	6.01e-05	0.000168	CcSEcCtD
Sertraline—Tachycardia—Betamethasone—psoriasis	5.99e-05	0.000168	CcSEcCtD
Sertraline—Tachycardia—Dexamethasone—psoriasis	5.99e-05	0.000168	CcSEcCtD
Sertraline—Angioedema—Prednisone—psoriasis	5.98e-05	0.000168	CcSEcCtD
Sertraline—Hypersensitivity—Cyclosporine—psoriasis	5.95e-05	0.000167	CcSEcCtD
Sertraline—Dyspepsia—Triamcinolone—psoriasis	5.95e-05	0.000167	CcSEcCtD
Sertraline—Erythema multiforme—Methotrexate—psoriasis	5.94e-05	0.000167	CcSEcCtD
Sertraline—Nausea—Mycophenolic acid—psoriasis	5.93e-05	0.000166	CcSEcCtD
Sertraline—Hyperhidrosis—Betamethasone—psoriasis	5.93e-05	0.000166	CcSEcCtD
Sertraline—Hyperhidrosis—Dexamethasone—psoriasis	5.93e-05	0.000166	CcSEcCtD
Sertraline—Feeling abnormal—Hydrocortisone—psoriasis	5.92e-05	0.000166	CcSEcCtD
Sertraline—Malaise—Prednisone—psoriasis	5.9e-05	0.000165	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—HLA-DRB1—psoriasis	5.9e-05	0.00188	CbGpPWpGaD
Sertraline—SLC6A2—Transmembrane transport of small molecules—CP—psoriasis	5.89e-05	0.00188	CbGpPWpGaD
Sertraline—Vertigo—Prednisone—psoriasis	5.88e-05	0.000165	CcSEcCtD
Sertraline—Eye disorder—Methotrexate—psoriasis	5.87e-05	0.000165	CcSEcCtD
Sertraline—Gastrointestinal pain—Hydrocortisone—psoriasis	5.87e-05	0.000165	CcSEcCtD
Sertraline—Syncope—Prednisone—psoriasis	5.87e-05	0.000165	CcSEcCtD
Sertraline—Tinnitus—Methotrexate—psoriasis	5.86e-05	0.000164	CcSEcCtD
Sertraline—Anorexia—Dexamethasone—psoriasis	5.85e-05	0.000164	CcSEcCtD
Sertraline—Anorexia—Betamethasone—psoriasis	5.85e-05	0.000164	CcSEcCtD
Sertraline—Urticaria—Prednisolone—psoriasis	5.84e-05	0.000164	CcSEcCtD
Sertraline—Cardiac disorder—Methotrexate—psoriasis	5.83e-05	0.000163	CcSEcCtD
Sertraline—Fatigue—Triamcinolone—psoriasis	5.83e-05	0.000163	CcSEcCtD
Sertraline—Hypersensitivity—Mycophenolate mofetil—psoriasis	5.81e-05	0.000163	CcSEcCtD
Sertraline—Asthenia—Cyclosporine—psoriasis	5.8e-05	0.000162	CcSEcCtD
Sertraline—Pain—Triamcinolone—psoriasis	5.78e-05	0.000162	CcSEcCtD
Sertraline—Loss of consciousness—Prednisone—psoriasis	5.75e-05	0.000161	CcSEcCtD
Sertraline—Hypotension—Betamethasone—psoriasis	5.73e-05	0.000161	CcSEcCtD
Sertraline—Hypotension—Dexamethasone—psoriasis	5.73e-05	0.000161	CcSEcCtD
Sertraline—Pruritus—Cyclosporine—psoriasis	5.72e-05	0.00016	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—JUN—psoriasis	5.71e-05	0.00182	CbGpPWpGaD
Sertraline—Urticaria—Hydrocortisone—psoriasis	5.7e-05	0.00016	CcSEcCtD
Sertraline—Angiopathy—Methotrexate—psoriasis	5.7e-05	0.00016	CcSEcCtD
Sertraline—Immune system disorder—Methotrexate—psoriasis	5.68e-05	0.000159	CcSEcCtD
Sertraline—Abdominal pain—Hydrocortisone—psoriasis	5.68e-05	0.000159	CcSEcCtD
Sertraline—Body temperature increased—Hydrocortisone—psoriasis	5.68e-05	0.000159	CcSEcCtD
Sertraline—Convulsion—Prednisone—psoriasis	5.67e-05	0.000159	CcSEcCtD
Sertraline—Mediastinal disorder—Methotrexate—psoriasis	5.66e-05	0.000159	CcSEcCtD
Sertraline—Asthenia—Mycophenolate mofetil—psoriasis	5.65e-05	0.000158	CcSEcCtD
Sertraline—Hypertension—Prednisone—psoriasis	5.65e-05	0.000158	CcSEcCtD
Sertraline—Chills—Methotrexate—psoriasis	5.64e-05	0.000158	CcSEcCtD
Sertraline—SLC6A2—Transmembrane transport of small molecules—CARM1—psoriasis	5.62e-05	0.00179	CbGpPWpGaD
Sertraline—Musculoskeletal discomfort—Betamethasone—psoriasis	5.59e-05	0.000157	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Dexamethasone—psoriasis	5.59e-05	0.000157	CcSEcCtD
Sertraline—Pruritus—Mycophenolate mofetil—psoriasis	5.58e-05	0.000156	CcSEcCtD
Sertraline—Arthralgia—Prednisone—psoriasis	5.57e-05	0.000156	CcSEcCtD
Sertraline—Myalgia—Prednisone—psoriasis	5.57e-05	0.000156	CcSEcCtD
Sertraline—Feeling abnormal—Triamcinolone—psoriasis	5.57e-05	0.000156	CcSEcCtD
Sertraline—Anxiety—Prednisone—psoriasis	5.55e-05	0.000156	CcSEcCtD
Sertraline—Alopecia—Methotrexate—psoriasis	5.55e-05	0.000156	CcSEcCtD
Sertraline—Insomnia—Dexamethasone—psoriasis	5.55e-05	0.000156	CcSEcCtD
Sertraline—Insomnia—Betamethasone—psoriasis	5.55e-05	0.000156	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	5.53e-05	0.000155	CcSEcCtD
Sertraline—Diarrhoea—Cyclosporine—psoriasis	5.53e-05	0.000155	CcSEcCtD
Sertraline—Paraesthesia—Betamethasone—psoriasis	5.51e-05	0.000154	CcSEcCtD
Sertraline—Paraesthesia—Dexamethasone—psoriasis	5.51e-05	0.000154	CcSEcCtD
Sertraline—Discomfort—Prednisone—psoriasis	5.51e-05	0.000154	CcSEcCtD
Sertraline—Mental disorder—Methotrexate—psoriasis	5.51e-05	0.000154	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—NFKB1—psoriasis	5.5e-05	0.00175	CbGpPWpGaD
Sertraline—Erythema—Methotrexate—psoriasis	5.47e-05	0.000153	CcSEcCtD
Sertraline—Malnutrition—Methotrexate—psoriasis	5.47e-05	0.000153	CcSEcCtD
Sertraline—Hypersensitivity—Prednisolone—psoriasis	5.42e-05	0.000152	CcSEcCtD
Sertraline—Dyspepsia—Dexamethasone—psoriasis	5.4e-05	0.000151	CcSEcCtD
Sertraline—Dyspepsia—Betamethasone—psoriasis	5.4e-05	0.000151	CcSEcCtD
Sertraline—Diarrhoea—Mycophenolate mofetil—psoriasis	5.39e-05	0.000151	CcSEcCtD
Sertraline—Urticaria—Triamcinolone—psoriasis	5.37e-05	0.000151	CcSEcCtD
Sertraline—Dysgeusia—Methotrexate—psoriasis	5.36e-05	0.00015	CcSEcCtD
Sertraline—Body temperature increased—Triamcinolone—psoriasis	5.34e-05	0.00015	CcSEcCtD
Sertraline—Dizziness—Cyclosporine—psoriasis	5.34e-05	0.00015	CcSEcCtD
Sertraline—Oedema—Prednisone—psoriasis	5.34e-05	0.00015	CcSEcCtD
Sertraline—Anaphylactic shock—Prednisone—psoriasis	5.34e-05	0.00015	CcSEcCtD
Sertraline—Decreased appetite—Betamethasone—psoriasis	5.33e-05	0.000149	CcSEcCtD
Sertraline—Decreased appetite—Dexamethasone—psoriasis	5.33e-05	0.000149	CcSEcCtD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	5.3e-05	0.00169	CbGpPWpGaD
Sertraline—Gastrointestinal disorder—Betamethasone—psoriasis	5.3e-05	0.000148	CcSEcCtD
Sertraline—Gastrointestinal disorder—Dexamethasone—psoriasis	5.3e-05	0.000148	CcSEcCtD
Sertraline—Back pain—Methotrexate—psoriasis	5.29e-05	0.000148	CcSEcCtD
Sertraline—Hypersensitivity—Hydrocortisone—psoriasis	5.29e-05	0.000148	CcSEcCtD
Sertraline—Fatigue—Dexamethasone—psoriasis	5.29e-05	0.000148	CcSEcCtD
Sertraline—Fatigue—Betamethasone—psoriasis	5.29e-05	0.000148	CcSEcCtD
Sertraline—Shock—Prednisone—psoriasis	5.26e-05	0.000147	CcSEcCtD
Sertraline—Pain—Betamethasone—psoriasis	5.25e-05	0.000147	CcSEcCtD
Sertraline—Pain—Dexamethasone—psoriasis	5.25e-05	0.000147	CcSEcCtD
Sertraline—Nervous system disorder—Prednisone—psoriasis	5.24e-05	0.000147	CcSEcCtD
Sertraline—SLC6A3—Transmembrane transport of small molecules—CP—psoriasis	5.21e-05	0.00166	CbGpPWpGaD
Sertraline—Tachycardia—Prednisone—psoriasis	5.21e-05	0.000146	CcSEcCtD
Sertraline—Dizziness—Mycophenolate mofetil—psoriasis	5.21e-05	0.000146	CcSEcCtD
Sertraline—Skin disorder—Prednisone—psoriasis	5.19e-05	0.000145	CcSEcCtD
Sertraline—Hyperhidrosis—Prednisone—psoriasis	5.16e-05	0.000145	CcSEcCtD
Sertraline—Asthenia—Hydrocortisone—psoriasis	5.15e-05	0.000144	CcSEcCtD
Sertraline—Vomiting—Cyclosporine—psoriasis	5.14e-05	0.000144	CcSEcCtD
Sertraline—MAOA—Metabolism—CYP2S1—psoriasis	5.13e-05	0.00164	CbGpPWpGaD
Sertraline—Rash—Cyclosporine—psoriasis	5.09e-05	0.000143	CcSEcCtD
Sertraline—Anorexia—Prednisone—psoriasis	5.09e-05	0.000143	CcSEcCtD
Sertraline—Dermatitis—Cyclosporine—psoriasis	5.09e-05	0.000143	CcSEcCtD
Sertraline—Pruritus—Hydrocortisone—psoriasis	5.08e-05	0.000142	CcSEcCtD
Sertraline—Ill-defined disorder—Methotrexate—psoriasis	5.08e-05	0.000142	CcSEcCtD
Sertraline—Headache—Cyclosporine—psoriasis	5.06e-05	0.000142	CcSEcCtD
Sertraline—Anaemia—Methotrexate—psoriasis	5.06e-05	0.000142	CcSEcCtD
Sertraline—Feeling abnormal—Betamethasone—psoriasis	5.05e-05	0.000142	CcSEcCtD
Sertraline—Feeling abnormal—Dexamethasone—psoriasis	5.05e-05	0.000142	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—CXCL8—psoriasis	5.03e-05	0.00161	CbGpPWpGaD
Sertraline—Gastrointestinal pain—Dexamethasone—psoriasis	5.02e-05	0.000141	CcSEcCtD
Sertraline—Gastrointestinal pain—Betamethasone—psoriasis	5.02e-05	0.000141	CcSEcCtD
Sertraline—Vomiting—Mycophenolate mofetil—psoriasis	5.01e-05	0.00014	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.99e-05	0.00159	CbGpPWpGaD
Sertraline—Hypersensitivity—Triamcinolone—psoriasis	4.98e-05	0.00014	CcSEcCtD
Sertraline—SLC6A3—Transmembrane transport of small molecules—CARM1—psoriasis	4.97e-05	0.00159	CbGpPWpGaD
Sertraline—Rash—Mycophenolate mofetil—psoriasis	4.97e-05	0.000139	CcSEcCtD
Sertraline—Dermatitis—Mycophenolate mofetil—psoriasis	4.96e-05	0.000139	CcSEcCtD
Sertraline—Headache—Mycophenolate mofetil—psoriasis	4.94e-05	0.000138	CcSEcCtD
Sertraline—Malaise—Methotrexate—psoriasis	4.93e-05	0.000138	CcSEcCtD
Sertraline—Vertigo—Methotrexate—psoriasis	4.91e-05	0.000138	CcSEcCtD
Sertraline—Diarrhoea—Hydrocortisone—psoriasis	4.91e-05	0.000138	CcSEcCtD
Sertraline—Leukopenia—Methotrexate—psoriasis	4.9e-05	0.000137	CcSEcCtD
Sertraline—Urticaria—Dexamethasone—psoriasis	4.87e-05	0.000137	CcSEcCtD
Sertraline—Urticaria—Betamethasone—psoriasis	4.87e-05	0.000137	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Prednisone—psoriasis	4.87e-05	0.000136	CcSEcCtD
Sertraline—Dizziness—Prednisolone—psoriasis	4.86e-05	0.000136	CcSEcCtD
Sertraline—Asthenia—Triamcinolone—psoriasis	4.85e-05	0.000136	CcSEcCtD
Sertraline—Abdominal pain—Betamethasone—psoriasis	4.85e-05	0.000136	CcSEcCtD
Sertraline—Abdominal pain—Dexamethasone—psoriasis	4.85e-05	0.000136	CcSEcCtD
Sertraline—Body temperature increased—Betamethasone—psoriasis	4.85e-05	0.000136	CcSEcCtD
Sertraline—Body temperature increased—Dexamethasone—psoriasis	4.85e-05	0.000136	CcSEcCtD
Sertraline—Insomnia—Prednisone—psoriasis	4.83e-05	0.000135	CcSEcCtD
Sertraline—Nausea—Cyclosporine—psoriasis	4.8e-05	0.000135	CcSEcCtD
Sertraline—Paraesthesia—Prednisone—psoriasis	4.8e-05	0.000134	CcSEcCtD
Sertraline—Pruritus—Triamcinolone—psoriasis	4.78e-05	0.000134	CcSEcCtD
Sertraline—Cough—Methotrexate—psoriasis	4.77e-05	0.000134	CcSEcCtD
Sertraline—Dizziness—Hydrocortisone—psoriasis	4.75e-05	0.000133	CcSEcCtD
Sertraline—Convulsion—Methotrexate—psoriasis	4.74e-05	0.000133	CcSEcCtD
Sertraline—Dyspepsia—Prednisone—psoriasis	4.7e-05	0.000132	CcSEcCtD
Sertraline—Nausea—Mycophenolate mofetil—psoriasis	4.68e-05	0.000131	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—JUN—psoriasis	4.68e-05	0.00149	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—JUN—psoriasis	4.66e-05	0.00149	CbGpPWpGaD
Sertraline—Arthralgia—Methotrexate—psoriasis	4.66e-05	0.000131	CcSEcCtD
Sertraline—Chest pain—Methotrexate—psoriasis	4.66e-05	0.000131	CcSEcCtD
Sertraline—Myalgia—Methotrexate—psoriasis	4.66e-05	0.000131	CcSEcCtD
Sertraline—Decreased appetite—Prednisone—psoriasis	4.64e-05	0.00013	CcSEcCtD
Sertraline—Rash—Prednisolone—psoriasis	4.64e-05	0.00013	CcSEcCtD
Sertraline—Dermatitis—Prednisolone—psoriasis	4.63e-05	0.00013	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	4.63e-05	0.00013	CcSEcCtD
Sertraline—Fatigue—Prednisone—psoriasis	4.61e-05	0.000129	CcSEcCtD
Sertraline—Headache—Prednisolone—psoriasis	4.61e-05	0.000129	CcSEcCtD
Sertraline—Discomfort—Methotrexate—psoriasis	4.6e-05	0.000129	CcSEcCtD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	4.58e-05	0.00146	CbGpPWpGaD
Sertraline—Constipation—Prednisone—psoriasis	4.57e-05	0.000128	CcSEcCtD
Sertraline—Vomiting—Hydrocortisone—psoriasis	4.57e-05	0.000128	CcSEcCtD
Sertraline—Rash—Hydrocortisone—psoriasis	4.53e-05	0.000127	CcSEcCtD
Sertraline—Dermatitis—Hydrocortisone—psoriasis	4.52e-05	0.000127	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—NFKB1—psoriasis	4.5e-05	0.00144	CbGpPWpGaD
Sertraline—Confusional state—Methotrexate—psoriasis	4.5e-05	0.000126	CcSEcCtD
Sertraline—Headache—Hydrocortisone—psoriasis	4.5e-05	0.000126	CcSEcCtD
Sertraline—Dizziness—Triamcinolone—psoriasis	4.47e-05	0.000125	CcSEcCtD
Sertraline—Anaphylactic shock—Methotrexate—psoriasis	4.46e-05	0.000125	CcSEcCtD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	4.41e-05	0.00141	CbGpPWpGaD
Sertraline—Feeling abnormal—Prednisone—psoriasis	4.4e-05	0.000123	CcSEcCtD
Sertraline—Asthenia—Betamethasone—psoriasis	4.4e-05	0.000123	CcSEcCtD
Sertraline—Asthenia—Dexamethasone—psoriasis	4.4e-05	0.000123	CcSEcCtD
Sertraline—Nervous system disorder—Methotrexate—psoriasis	4.38e-05	0.000123	CcSEcCtD
Sertraline—Thrombocytopenia—Methotrexate—psoriasis	4.37e-05	0.000123	CcSEcCtD
Sertraline—Gastrointestinal pain—Prednisone—psoriasis	4.37e-05	0.000122	CcSEcCtD
Sertraline—Nausea—Prednisolone—psoriasis	4.37e-05	0.000122	CcSEcCtD
Sertraline—Pruritus—Dexamethasone—psoriasis	4.34e-05	0.000122	CcSEcCtD
Sertraline—Pruritus—Betamethasone—psoriasis	4.34e-05	0.000122	CcSEcCtD
Sertraline—Skin disorder—Methotrexate—psoriasis	4.34e-05	0.000122	CcSEcCtD
Sertraline—Hyperhidrosis—Methotrexate—psoriasis	4.32e-05	0.000121	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—IFNG—psoriasis	4.31e-05	0.00138	CbGpPWpGaD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—JUN—psoriasis	4.3e-05	0.00137	CbGpPWpGaD
Sertraline—Vomiting—Triamcinolone—psoriasis	4.3e-05	0.00012	CcSEcCtD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	4.27e-05	0.00136	CbGpPWpGaD
Sertraline—Nausea—Hydrocortisone—psoriasis	4.26e-05	0.00012	CcSEcCtD
Sertraline—Rash—Triamcinolone—psoriasis	4.26e-05	0.000119	CcSEcCtD
Sertraline—Dermatitis—Triamcinolone—psoriasis	4.26e-05	0.000119	CcSEcCtD
Sertraline—Anorexia—Methotrexate—psoriasis	4.26e-05	0.000119	CcSEcCtD
Sertraline—Urticaria—Prednisone—psoriasis	4.24e-05	0.000119	CcSEcCtD
Sertraline—Headache—Triamcinolone—psoriasis	4.24e-05	0.000119	CcSEcCtD
Sertraline—Abdominal pain—Prednisone—psoriasis	4.22e-05	0.000118	CcSEcCtD
Sertraline—Body temperature increased—Prednisone—psoriasis	4.22e-05	0.000118	CcSEcCtD
Sertraline—Diarrhoea—Dexamethasone—psoriasis	4.2e-05	0.000118	CcSEcCtD
Sertraline—Diarrhoea—Betamethasone—psoriasis	4.2e-05	0.000118	CcSEcCtD
Sertraline—Hypotension—Methotrexate—psoriasis	4.17e-05	0.000117	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—VEGFA—psoriasis	4.09e-05	0.00131	CbGpPWpGaD
Sertraline—Musculoskeletal discomfort—Methotrexate—psoriasis	4.07e-05	0.000114	CcSEcCtD
Sertraline—Dizziness—Betamethasone—psoriasis	4.06e-05	0.000114	CcSEcCtD
Sertraline—Dizziness—Dexamethasone—psoriasis	4.06e-05	0.000114	CcSEcCtD
Sertraline—Insomnia—Methotrexate—psoriasis	4.04e-05	0.000113	CcSEcCtD
Sertraline—Nausea—Triamcinolone—psoriasis	4.02e-05	0.000113	CcSEcCtD
Sertraline—Paraesthesia—Methotrexate—psoriasis	4.01e-05	0.000112	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—CXCL8—psoriasis	4.01e-05	0.00128	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	4.01e-05	0.00128	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CARM1—psoriasis	3.99e-05	0.00128	CbGpPWpGaD
Sertraline—Dyspnoea—Methotrexate—psoriasis	3.98e-05	0.000112	CcSEcCtD
Sertraline—Somnolence—Methotrexate—psoriasis	3.97e-05	0.000111	CcSEcCtD
Sertraline—Hypersensitivity—Prednisone—psoriasis	3.94e-05	0.00011	CcSEcCtD
Sertraline—Dyspepsia—Methotrexate—psoriasis	3.93e-05	0.00011	CcSEcCtD
Sertraline—Vomiting—Dexamethasone—psoriasis	3.9e-05	0.000109	CcSEcCtD
Sertraline—Vomiting—Betamethasone—psoriasis	3.9e-05	0.000109	CcSEcCtD
Sertraline—Decreased appetite—Methotrexate—psoriasis	3.88e-05	0.000109	CcSEcCtD
Sertraline—Rash—Dexamethasone—psoriasis	3.87e-05	0.000108	CcSEcCtD
Sertraline—Rash—Betamethasone—psoriasis	3.87e-05	0.000108	CcSEcCtD
Sertraline—Dermatitis—Betamethasone—psoriasis	3.86e-05	0.000108	CcSEcCtD
Sertraline—Dermatitis—Dexamethasone—psoriasis	3.86e-05	0.000108	CcSEcCtD
Sertraline—Gastrointestinal disorder—Methotrexate—psoriasis	3.85e-05	0.000108	CcSEcCtD
Sertraline—Fatigue—Methotrexate—psoriasis	3.85e-05	0.000108	CcSEcCtD
Sertraline—Headache—Betamethasone—psoriasis	3.84e-05	0.000108	CcSEcCtD
Sertraline—Headache—Dexamethasone—psoriasis	3.84e-05	0.000108	CcSEcCtD
Sertraline—Asthenia—Prednisone—psoriasis	3.83e-05	0.000107	CcSEcCtD
Sertraline—Pain—Methotrexate—psoriasis	3.82e-05	0.000107	CcSEcCtD
Sertraline—CYP2B6—Metabolism—NDUFA5—psoriasis	3.78e-05	0.00121	CbGpPWpGaD
Sertraline—Pruritus—Prednisone—psoriasis	3.78e-05	0.000106	CcSEcCtD
Sertraline—ABCB1—HIF-1-alpha transcription factor network—VEGFA—psoriasis	3.76e-05	0.0012	CbGpPWpGaD
Sertraline—Feeling abnormal—Methotrexate—psoriasis	3.68e-05	0.000103	CcSEcCtD
Sertraline—Diarrhoea—Prednisone—psoriasis	3.66e-05	0.000102	CcSEcCtD
Sertraline—Gastrointestinal pain—Methotrexate—psoriasis	3.65e-05	0.000102	CcSEcCtD
Sertraline—Nausea—Dexamethasone—psoriasis	3.64e-05	0.000102	CcSEcCtD
Sertraline—Nausea—Betamethasone—psoriasis	3.64e-05	0.000102	CcSEcCtD
Sertraline—Urticaria—Methotrexate—psoriasis	3.55e-05	9.94e-05	CcSEcCtD
Sertraline—Dizziness—Prednisone—psoriasis	3.53e-05	9.9e-05	CcSEcCtD
Sertraline—Abdominal pain—Methotrexate—psoriasis	3.53e-05	9.89e-05	CcSEcCtD
Sertraline—Body temperature increased—Methotrexate—psoriasis	3.53e-05	9.89e-05	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—TNF—psoriasis	3.5e-05	0.00112	CbGpPWpGaD
Sertraline—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	3.45e-05	0.0011	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	3.43e-05	0.0011	CbGpPWpGaD
Sertraline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	3.43e-05	0.0011	CbGpPWpGaD
Sertraline—Vomiting—Prednisone—psoriasis	3.4e-05	9.52e-05	CcSEcCtD
Sertraline—Rash—Prednisone—psoriasis	3.37e-05	9.44e-05	CcSEcCtD
Sertraline—Dermatitis—Prednisone—psoriasis	3.37e-05	9.43e-05	CcSEcCtD
Sertraline—Headache—Prednisone—psoriasis	3.35e-05	9.38e-05	CcSEcCtD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	3.3e-05	0.00105	CbGpPWpGaD
Sertraline—Hypersensitivity—Methotrexate—psoriasis	3.29e-05	9.22e-05	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—VEGFA—psoriasis	3.26e-05	0.00104	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CYP2S1—psoriasis	3.22e-05	0.00103	CbGpPWpGaD
Sertraline—Asthenia—Methotrexate—psoriasis	3.2e-05	8.98e-05	CcSEcCtD
Sertraline—Nausea—Prednisone—psoriasis	3.17e-05	8.89e-05	CcSEcCtD
Sertraline—Pruritus—Methotrexate—psoriasis	3.16e-05	8.85e-05	CcSEcCtD
Sertraline—SLC6A4—Circadian rythm related genes—TP53—psoriasis	3.08e-05	0.000982	CbGpPWpGaD
Sertraline—Diarrhoea—Methotrexate—psoriasis	3.05e-05	8.56e-05	CcSEcCtD
Sertraline—Dizziness—Methotrexate—psoriasis	2.95e-05	8.28e-05	CcSEcCtD
Sertraline—CYP2C19—Metabolism—NDUFA5—psoriasis	2.86e-05	0.000912	CbGpPWpGaD
Sertraline—Vomiting—Methotrexate—psoriasis	2.84e-05	7.96e-05	CcSEcCtD
Sertraline—MAOA—SIDS Susceptibility Pathways—IL6—psoriasis	2.83e-05	0.000903	CbGpPWpGaD
Sertraline—SLC6A4—Circadian rythm related genes—IL6—psoriasis	2.82e-05	0.000899	CbGpPWpGaD
Sertraline—Rash—Methotrexate—psoriasis	2.81e-05	7.89e-05	CcSEcCtD
Sertraline—Dermatitis—Methotrexate—psoriasis	2.81e-05	7.88e-05	CcSEcCtD
Sertraline—Headache—Methotrexate—psoriasis	2.8e-05	7.84e-05	CcSEcCtD
Sertraline—ABCB1—Allograft Rejection—TNF—psoriasis	2.79e-05	0.000891	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—NDUFA5—psoriasis	2.79e-05	0.00089	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	2.77e-05	0.000885	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.66e-05	0.000851	CbGpPWpGaD
Sertraline—Nausea—Methotrexate—psoriasis	2.65e-05	7.43e-05	CcSEcCtD
Sertraline—CYP2D6—Metabolism—NDUFA5—psoriasis	2.63e-05	0.000839	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—NDUFA5—psoriasis	2.61e-05	0.000832	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—CP—psoriasis	2.59e-05	0.000827	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CARM1—psoriasis	2.51e-05	0.0008	CbGpPWpGaD
Sertraline—ABCB1—Transmembrane transport of small molecules—CARM1—psoriasis	2.47e-05	0.000789	CbGpPWpGaD
Sertraline—MAOB—Metabolism—CAT—psoriasis	2.46e-05	0.000784	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CYP2S1—psoriasis	2.43e-05	0.000776	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.43e-05	0.000776	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CYP2S1—psoriasis	2.37e-05	0.000757	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CYP2S1—psoriasis	2.23e-05	0.000713	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—NDUFA5—psoriasis	2.23e-05	0.000711	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CYP2S1—psoriasis	2.22e-05	0.000707	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	2.08e-05	0.000663	CbGpPWpGaD
Sertraline—MAOB—Metabolism—APOE—psoriasis	1.91e-05	0.00061	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CYP2S1—psoriasis	1.89e-05	0.000604	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	1.84e-05	0.000587	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	1.77e-05	0.000565	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—NDUFA5—psoriasis	1.72e-05	0.000549	CbGpPWpGaD
Sertraline—MAOB—Metabolism—PPARG—psoriasis	1.66e-05	0.000531	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	1.61e-05	0.000513	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CARM1—psoriasis	1.57e-05	0.000501	CbGpPWpGaD
Sertraline—MAOA—Metabolism—CAT—psoriasis	1.54e-05	0.000492	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CYP2S1—psoriasis	1.46e-05	0.000466	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	1.38e-05	0.00044	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.27e-05	0.000407	CbGpPWpGaD
Sertraline—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	1.21e-05	0.000387	CbGpPWpGaD
Sertraline—MAOA—Metabolism—APOE—psoriasis	1.2e-05	0.000382	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CARM1—psoriasis	1.19e-05	0.000379	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	1.16e-05	0.000371	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CARM1—psoriasis	1.16e-05	0.00037	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.11e-05	0.000354	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CARM1—psoriasis	1.09e-05	0.000348	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CARM1—psoriasis	1.08e-05	0.000345	CbGpPWpGaD
Sertraline—MAOA—Metabolism—PPARG—psoriasis	1.04e-05	0.000333	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	1.01e-05	0.000323	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	9.92e-06	0.000317	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—CAT—psoriasis	9.66e-06	0.000308	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CARM1—psoriasis	9.25e-06	0.000295	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	8.64e-06	0.000276	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—APOE—psoriasis	7.5e-06	0.00024	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—CAT—psoriasis	7.3e-06	0.000233	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CARM1—psoriasis	7.14e-06	0.000228	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—CAT—psoriasis	7.12e-06	0.000227	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—CAT—psoriasis	6.71e-06	0.000214	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—CAT—psoriasis	6.65e-06	0.000212	CbGpPWpGaD
Sertraline—CYP2B6—Metabolism—PPARG—psoriasis	6.54e-06	0.000209	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—CAT—psoriasis	5.69e-06	0.000182	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—APOE—psoriasis	5.67e-06	0.000181	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—APOE—psoriasis	5.53e-06	0.000177	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—APOE—psoriasis	5.22e-06	0.000167	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—APOE—psoriasis	5.17e-06	0.000165	CbGpPWpGaD
Sertraline—CYP2C19—Metabolism—PPARG—psoriasis	4.94e-06	0.000158	CbGpPWpGaD
Sertraline—ABCB1—Metabolism—PPARG—psoriasis	4.82e-06	0.000154	CbGpPWpGaD
Sertraline—CYP2D6—Metabolism—PPARG—psoriasis	4.54e-06	0.000145	CbGpPWpGaD
Sertraline—CYP2C9—Metabolism—PPARG—psoriasis	4.5e-06	0.000144	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—APOE—psoriasis	4.42e-06	0.000141	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—CAT—psoriasis	4.39e-06	0.00014	CbGpPWpGaD
Sertraline—CYP1A2—Metabolism—PPARG—psoriasis	3.85e-06	0.000123	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—APOE—psoriasis	3.41e-06	0.000109	CbGpPWpGaD
Sertraline—CYP3A4—Metabolism—PPARG—psoriasis	2.97e-06	9.48e-05	CbGpPWpGaD
